Results 111 to 120 of about 5,357,473 (408)

Identification of Cervical Pathology using Adversarial Neural Networks [PDF]

arXiv, 2020
Various screening and diagnostic methods have led to a large reduction of cervical cancer death rates in developed countries. However, cervical cancer is the leading cause of cancer related deaths in women in India and other low and middle income countries (LMICs) especially among the urban poor and slum dwellers.
arxiv  

Effectiveness of opportunistic screening for cancer of the cervix uteri [PDF]

, 2006
The incidence and mortality of uterine cervical cancer in the Maltese Islands has remained relatively constant in medical records of the last few decades.
Busuttil, Roderick, Cilia Vincenti, Albert, Dalmas, Miriam   +2 more
core  

Simple models of the chemical field around swimming plankton [PDF]

, 2010
Background. Cervical cancer is the fourth most common cancer in women, and we recently reported human leukocyte antigen (HLA) alleles showing strong associations with cervical neoplasia risk and protection.
Bao, X, Brown, MA, Castro, F, Cortes, A, Coutlée, F, Cremin, K, Cruickshank, M, Duncan, EL, Franco, EL, Frazer, IH, Garland, SM, Hanson, AL, Hemminki, K, Hildesheim, A, Johnson, LG, Leo, PJ, Little, J, Madeleine, MM, Marshall, M, Mukhopadhyay, P, Newell, F, Ohlsson, C, Pettersson-Kymmer, U, Rader, JS, Safaeian, M, Schwartz, SM, Sitas, F, Steinberg, W, Sun, YP, Tabrizi, SN, Tiews, S, Trimble, C, Wang, SS, Wentzensen, N   +33 more
core   +2 more sources

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer

Nature Communications
HPV vaccination with concomitant HPV-based screening of young women has been proposed for faster cervical cancer elimination. We describe the baseline results of a population-based trial of this strategy to reduce the incidence of HPV.
Laila Sara Arroyo Mühr, Andrea Gini, Emel Yilmaz, Sadaf S. Hassan, Camilla Lagheden, Emilie Hultin, Ainhoa Garcia Serrano, Agustin E. Ure, Helena Andersson, Roxana Merino, K. Miriam Elfström, Iacopo Baussano, Joakim Dillner   +12 more
doaj   +1 more source

Gaps in detailed knowledge of human papillomavirus (HPV) and the HPV vaccine among medical students in Scotland [PDF]

, 2013
<p>Background: A vaccination programme targeted against human papillomavirus (HPV) types16 and 18 was introduced in the UK in 2008, with the aim of decreasing incidence of cervical disease.
A Das, A Szarewski, Alasdair I MacDonald, AS Licht, CBJ Woodman, CD Walsh, CE Schmeink, Christine Campbell, D Metcalfe, F Samkange-Zeeb, GP Lloyd, Graham Lough, H zur Hausen, HL Bowyer, Ishbel Macqueen, JA Tiro, K Cuschieri, K Trim, K Williams, L Bell, LAV Marlow, LAV Marlow, M Mosavel, M Pitts, MA Stanley, N Ghotbi, N Munoz, P Juntasopeepun, R Caskey, S Blödt, S Hilton, Sarah M McCusker, SC Cooper Robbins, Sheila V Graham, SJ Klug   +34 more
core   +2 more sources

Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2019
Cervical cancer is a malignant epithelial tumor that forms in the uterine cervix. Most cases of cervical cancer are preventable through human papilloma virus (HPV) vaccination, routine screening, and treatment of precancerous lesions.
W. Koh, N. Abu-Rustum, S. Bean, K. Bradley, S. Campos, Kathleen R. Cho, H. Chon, C. Chu, R. Clark, D. Cohn, M. Crispens, S. Damast, O. Dorigo, P. Eifel, C. Fisher, P. Frederick, D. Gaffney, E. Han, W. Huh, J. Lurain, A. Mariani, D. Mutch, C. Nagel, L. Nekhlyudov, A. Fader, S. Remmenga, R. Reynolds, T. Tillmanns, S. Ueda, E. Wyse, C. Yashar, Nicole R Mcmillian, Jillian L. Scavone   +32 more
semanticscholar   +1 more source

Trends in cervical cancer incidence in sub-Saharan Africa

British Journal of Cancer, 2020
Background Cervical cancer is the second most common cancer and the leading cause of cancer death in women in sub-Saharan Africa (SSA). Methods Trends in the incidence of cervical cancer are examined for a period of 10–25 years in 10 population-based ...
E. Jedy-Agba, Walburga Yvonne A Joko, Biying Liu, N. Buziba, M. Borok, A. Korir, L. Masamba, S. Manraj, Anne Finesse, H. Wabinga, N. Somdyala, D. Parkin   +11 more
semanticscholar   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Researchers should no longer delay implementation of Pap screening in low and middle income countries pending research into novel screening approaches

Infectious Agents and Cancer
A study coordinated by Groesbeck Parham and Mark Schiffman describes a novel approach to single-visit, point-of-care cervical screening and triage for low and middle income countries (LMICs) that uses an HPV screening test that is not affordable in LMICs
Eric J Suba
doaj   +1 more source